Animal Health Vaccine – FED



A new veterinary biopharma production plant for the production of an animal virus antigen was developed from concept to a front end engineering stage in collaboration  with a partner.

The new facility is stand alone on an existing site that comprises all process services and utilities to produce the antigen.

The manufacturing unit consists of technical areas, uncontained process areas and contained (SAPO4)areas.








BPE in conjunction with a partner led the technology development based on existing production methods of media preparation, cells amplification, antigen formation and purification. The deliverables included:

  • PFD’s
  • P&ID’s
  • Equipment Specification
  • Equipment Layouts
  • Control Specification
  • 3D Model
  • Vendor Enquiries